Evidence map›Paper›PMID 32667096›Full record

ArticleDepression and anxiety2020

Perceived helpfulness of treatment for posttraumatic stress disorder: Findings from the World Mental Health Surveys.

Dan J Stein, Meredith G Harris, Daniel V Vigo, Wai Tat Chiu, Nancy Sampson, Jordi Alonso, Yasmin Altwaijri, Brendan Bunting, José Miguel Caldas-de-Almeida, Alfredo Cía and 16 more

Abstract read
In one paragraph

Article in Depression and anxiety, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Dan J SteinDepartment of Psychiatry & Mental Health and South African Medical Council Research Unit on Risk and Resilience in Mental Disorders, University of Cape Town and Groote Schuur Hospital, Cape Town, Republic of South Africa.
Meredith G HarrisSchool of Public Health, The University of Queensland, Herston, Australia.
Daniel V VigoDepartment of Psychiatry, University of British Columbia, Vancouver, Canada.
Wai Tat ChiuDepartment of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
Nancy SampsonDepartment of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
Jordi AlonsoHealth Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain.ORCID 0000-0001-8627-9636
Yasmin AltwaijriEpidemiology Section, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Brendan BuntingSchool of Psychology, Ulster University, Londonderry, United Kingdom.
José Miguel Caldas-de-AlmeidaLisbon Institute of Global Mental Health and Chronic Diseases Research Center (CEDOC), NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal.
Alfredo CíaAnxiety Disorders Center, Buenos Aires, Argentina.
Marius CiutanNational School of Public Health, Management and Professional Development, Bucharest, Romania.
Louisa DegenhardtNational Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia.
Oye GurejeDepartment of Psychiatry, University College Hospital, Ibadan, Nigeria.
Aimee KaramInstitute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon.
Elie G KaramInstitute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon.
Sing LeeDepartment of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong.
Maria Elena Medina-MoraNational Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.
Zeina MneimnehSurvey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, Michigan.
Fernando Navarro-MateuUDIF-SM, Servicio Murciano de Salud, Murcia, Spain.
José Posada-VillaFaculty of Social Sciences, Colegio Mayor de Cundinamarca University, Bogota, Colombia.
Charlene RapseyDepartment of Psychological Medicine, University of Otago, Dunedin, New Zealand.
Yolanda TorresCenter for Excellence on Research in Mental Health, CES University, Medellin, Colombia.
Maria Carmen VianaDepartment of Social Medicine, Postgraduate Program in Public Health, Federal University of Espírito Santo, Vitoria, Brazil.
Yuval ZivMental Health Services, Israeli Ministry of Health, Jerusalem, Israel.
Ronald C KesslerDepartment of Health Care Policy, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0003-4831-2305
WHO World Mental Health Survey Collaborators

Funding

EPIDEMIOLOGY-- NATIONAL COMORBIDITY SURVEY REPLICATIONU01MH060220 · NIMH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KESSLER, RONALD C · 1999 to 2010
$18.7M
Risk Factors for Psychopathology in the WHO WMH SurveysR01MH070884 · NIMH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KESSLER, RONALD C · 2005 to 2009
$6.0M
Social Role Disability and Mental-Physical Co-MorbidityR01MH069864 · NIMH · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI VON KORFF, MICHAEL R · 2004 to 2007
$2.2M
CROSS-NATIONAL STUDIES OF DRUG INVOLVEMENT: WMH2000R01DA016558 · NIDA · MICHIGAN STATE UNIVERSITY · PI ANTHONY, JAMES CHRISTOPHER · 2003 to 2008
$1.7M
World Mental Health Consortium Annual Meeting 2003-07R13MH066849 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HEERINGA, STEVEN G · 2003 to 2007
$735k
Lebanon-Epidemiology: The NCS Replication StudyR03TW006481 · FIC · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI KESSLER, RONALD C · 2004 to 2006
$142k
Alcohol Advisory Council of New ZealandAlgorithmAstraZenecaAustralian Government Department of Health and AgeingBella PharmaBentaBristol-Myers SquibbCalouste Gulbenkian FoundationCenter for Excellence on Research in Mental Health (CES University)Champalimaud FoundationComunidad Autónoma de la Región de MurciaEEA GrantsEli Lilly and CompanyEli Lilly Romania SRLFederal Ministry of Health, Abuja, NigeriaFIC NIH HHS R03 TW006481Foundation for Science and Technology (FCT)Fundación para la Formación e Investigación Sanitarias de la Región de MurciaGlaxoSmithKlineHealth & Social Care Research & Development Division of the Public Health AgencyHealth Research Council of New ZealandIDRAAC, LebanonIsrael National Institute for Health Policy and Health Services ResearchJapan Ministry of Health, Labour and Welfare H13-SHOGAI-023Japan Ministry of Health, Labour and Welfare H14-TOKUBETSU-026Japan Ministry of Health, Labour and Welfare H16-KOKORO-013Japan Ministry of Health, Labour and Welfare H25-SEISHIN-IPPAN-006John D. and Catherine T. MacArthur FoundationJohn W. Alden TrustKing Abdulaziz City for Science and Technology (KACST)King Faisal Specialist Hospital and Research CenterKing Saud UniversityLebanese Ministry of Public HealthLundbeckMedical Research Council of South Africa (MRC)Ministerio de Salud de la Nación 2002-17270/13 - 5Ministry of Economy and Planning, General Authority for Statistics, Saudi ArabiaMinistry of Health, BulgariaMinistry of Health, New ZealandMinistry of Health, PortugalMinistry of Health, Saudi ArabiaMinistry of Health, State of IsraelMinistry of Public Health, RomaniaMinistry of Social Protection, ColombiaNational Center for Public Health Protection, BulgariaNational Council on Science and Technology CONACyT-G30544- HNational Institute of Drug Abuse (NIDA)National Institute of Psychiatry Ramon de la Fuente INPRFMDIES 4280National Insurance Institute of IsraelNIDA NIH HHS R01 DA016558NIMH NIH HHS R01 MH069864NIMH NIH HHS R01 MH070884NIMH NIH HHS R13 MH066849NIMH NIH HHS U01 MH060220NovartisOmniPharmaOrtho-McNeil Pharmaceutical Inc.Pan American Health OrganizationPfizerPfizer FoundationPheniciaRobert Wood Johnson Foundation 044708SAMHSA HHSSaudi Arabia Ministry of Economy and Planning, General Authority for StatisticsSaudi Basic Industries Corporation (SABIC)Secretary of Health of MedellínServierState of São Paulo Research Foundation (FAPESP) 03/00204-3UPOU.S. Public Health Service R13-MH066849World Health OrganizationWorld Health Organization (Lebanon)World Health Organization (Nigeria)
6 · The paper itself

Abstract

backgroundPerceived helpfulness of treatment is an important healthcare quality indicator in the era of patient-centered care. We examine probability and predictors of two key components of this indicator for posttraumatic stress disorder (PTSD).

methodsData come from World Mental Health surveys in 16 countries. Respondents who ever sought PTSD treatment (n = 779) were asked if treatment was ever helpful and, if so, the number of professionals they had to see to obtain helpful treatment. Patients whose treatment was never helpful were asked how many professionals they saw. Parallel survival models were estimated for obtaining helpful treatment in a specific encounter and persisting in help-seeking after earlier unhelpful encounters.

resultsFifty seven percent of patients eventually received helpful treatment, but survival analysis suggests that it would have been 85.7% if all patients had persisted in help-seeking with up to six professionals after earlier unhelpful treatment. Survival analysis suggests that only 23.6% of patients would persist to that extent. Odds of ever receiving helpful treatment were positively associated with receiving treatment from a mental health professional, short delays in initiating help-seeking after onset, absence of prior comorbid anxiety disorders and childhood adversities, and initiating treatment before 2000. Some of these variables predicted helpfulness of specific treatment encounters and others predicted persistence after earlier unhelpful encounters.

conclusionsThe great majority of patients with PTSD would receive treatment they considered helpful if they persisted in help-seeking after initial unhelpful encounters, but most patients whose initial treatment is unhelpful give up before receiving helpful treatment.

Indexed as

Stress Disorders, Post-TraumaticAnxietyChildHealth SurveysHumansPatient Acceptance of Health CareSurveys and Questionnairescross nationalepidemiologyhealth servicesPTSDtraumatreatment

Identifiers

PMID32667096
PMCPMC7722199

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.